USPTO 2015–2025 USPTO PatentsView US Corporation

Immunology Laboratories, Inc.

USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).

RSS updates for this company

The verdict

According to USPTO PatentsView, Immunology ranks #47,625 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.

#47,625
of 49,997 US assignees by volume
7th percentile
by Innovation Score (20.7/100)
11.0
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R47625 · US Corporation #47,625 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 5 grants
  • BOTTOM-DECILE #47,625/49,997
  • PHOTO-FINISH Immortazyme
  • CPC-NARROW C12P · 5 areas
  • INNOV-THIN 20.7/100
  • CLAIMS-PAR 11.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Immortazyme Company Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Immunology

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Immunology's Innovation Score is 20.7/100 (7th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Immunology's grants concentrate

Immunology Laboratories, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2015. By volume, Immunology sits between Immortazyme Company Ltd. and InTunes Products, LLC.

Who files at Immunology's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Immunology holds 5 patents at rank #47,765, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Immunology

By rank, the assignees closest to #47,765 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Immunology's primary technology class.

Immunology's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

21 7th percentile higher than 7% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 2015201620172018 1
USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Immunology Laboratories, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 20.0%
2016 2 40.0%
2017 1 20.0%
2018 1 20.0%

Where it ranks

Overall rank by patents

#47,625

of 49,997 tracked assignees

Innovation Score

20.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Immunology Laboratories, Inc.'s patent record in context - here's where to go next.

  • Immunology Laboratories, Inc.'s lead technology class is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture), 100% of its portfolio - see every assignee active in that class. Explore C12P
  • Ranked #47,625 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Immunology Laboratories, Inc. against Immortazyme Company Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 20.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.